pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 30·1 min read
save

What we heard at a health tech conference in Boston

I just came back from the Digital Healthcare Innovation Summit in Boston earlier this week, where I got a good look into what investors are thinking about. A few impressions: Investors see a ...

Apr 30, 2026·read at Endpoints ↗

April 30, 2026 10:29 AM EDT Health Tech What we heard at a health tech con­fer­ence in Boston Ngai Yeung Health Tech Reporter I just came back from the Dig­i­tal Health­care In­no­va­tion Sum­mit in Boston ear­li­er this week, where I got a good look in­to what in­vestors are … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
83 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 6h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 10h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 10h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 10h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 11h agoHealth tech investors are looking at bigger betsEndpoints